Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the guidance entitled The two-week wait skin cancer pathway: innovative approaches to support early diagnosis of skin cancer as part of the NHS COVID-19 recovery plan, published by NHS England on 4 April 2022, whether (a) his Department and (b) NHS England are taking steps to monitor implementation of service delivery models in the guidance by integrated care boards.

NHS England are responsible for monitoring the implementation of teledermatology services via several routes. Where possible, data has been collected directly from dermatology services by Cancer Alliances. In the 2023/24 financial year, NHS England are asking National Health Service trusts in England to collect and submit data on implementation of teledermatology in cancer pathways through a quarterly snapshot audit. NHS England continues to work with key partners, particularly the British Association of Dermatologists, who also have considerable intelligence on the extent to which teledermatology services have been implemented so far